Latest Conference Coverage


Ricardo Osorio, MD: Unanswered Questions About the Relationship Between Sleep, Alzheimer Disease

Ricardo Osorio, MD: Unanswered Questions About the Relationship Between Sleep, Alzheimer Disease

November 16th 2018

The associate professor at NYU Langone discussed several of the questions that remained unanswered about the relationship between sleep and Alzheimer disease.


Does Cannabis Have Potential Therapeutic Use in Migraine, Headache?

Does Cannabis Have Potential Therapeutic Use in Migraine, Headache?

November 16th 2018

While studies support the use of cannabis for pain in adults, a lack of clinical data and an inability to perform studies has slowed the medical community’s understanding of the drug’s conceivable use in headache conditions.


Asher J. Albertson, MD, PhD: Getting Interventions to Stroke Patients

Asher J. Albertson, MD, PhD: Getting Interventions to Stroke Patients

November 15th 2018

Albertson discussed this facet of stroke care, and all the things being done outside just the clinic to help improve outcomes.


Ricardo Osorio, MD, on the Association Between Sleep-Wake Disruptions, Pathogenesis of Alzheimer

Ricardo Osorio, MD, on the Association Between Sleep-Wake Disruptions, Pathogenesis of Alzheimer

November 14th 2018

The associate professor at NYU Langone discussed emerging evidence that suggests that sleep disruption results in higher levels of markers associated with Alzheimer disease.


Ethical Issues Raised by Novel Therapies

Ethical Issues Raised by Novel Therapies

November 13th 2018

The Carolyn and Matthew Bucksbaum Professor of Clinical Ethics at the University of Chicago spoke about the ethical considerations of spinal muscular atrophy and its treatment.


Ari Green, MD, MCR: Remyelination in Multiple Sclerosis

Ari Green, MD, MCR: Remyelination in Multiple Sclerosis

November 12th 2018

The medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.


Costantino Iadecola, MD: The Cost of Dementia's Increasing Prevalence

Costantino Iadecola, MD: The Cost of Dementia's Increasing Prevalence

November 10th 2018

The Anne Parrish Titzell Professor of Neurology and Neuroscience at Weill Cornell Medicine’s Feil Family Brain and Mind Research Institute spoke about the cost the condition has for patients and their families.


Rolf Fronczek, PhD, MD: Cluster Headaches and Sleep

Rolf Fronczek, PhD, MD: Cluster Headaches and Sleep

November 9th 2018

Recent work demonstrates that the anterior part of the hypothalamus is enlarged in cluster headache.


Claudia Testa, MD, PhD: Advancements Made in Huntington Disease Treatment

Claudia Testa, MD, PhD: Advancements Made in Huntington Disease Treatment

November 7th 2018

The professor of neurology at Virginia Commonwealth University discussed all the progress that’s been made in the space and shared her thoughts on the advances.


Addressing Cognitive Issues In Patients With Epilepsy

Addressing Cognitive Issues In Patients With Epilepsy

November 5th 2018

Cognitive complaints remain a major issue for patients with epilepsy, leading the epileptologist at the University of Pennsylvania to share her insight into addressing them.


Joshua Cohen, MD: Fremanezumab's Impact on Quality of Life and Comorbidities

Joshua Cohen, MD: Fremanezumab's Impact on Quality of Life and Comorbidities

November 5th 2018

The Global Medical Lead for Migraine and Headache at Teva Pharmaceuticals provided insight into how fremanezumab has helped to improve these facets of the condition.


Rolf Fronczek, PhD, MD: Narcolepsy and Opiates

Rolf Fronczek, PhD, MD: Narcolepsy and Opiates

November 3rd 2018

The neurologist discussed an analysis of findings suggesting that opiate agonists may have a role in the treatment of narcolepsy.


Epilepsy, the Perfect Paradigm in Implementing Telemedicine

Epilepsy, the Perfect Paradigm in Implementing Telemedicine

November 3rd 2018

The clinical professor in pediatric neurology and director of regional neurology services at Children's Hospital Colorado shared her thoughts on why epilepsy is the perfect paradigm to implement telemedicine.


Robert J. Fox, MD: Treating Progressive Multiple Sclerosis

Robert J. Fox, MD: Treating Progressive Multiple Sclerosis

November 2nd 2018

The neurologist from Cleveland Clinic discussed the challenges of treating progressive MS, and shared his clinical experience with ibudilast.


Dystonia, A Disorder Longing for More Therapies

Dystonia, A Disorder Longing for More Therapies

November 2nd 2018

The Pediatric Movement Disorders Neurologist at UT Southwestern recommends that when encountering a patient with a movement disorder to organize your thought process in 3 steps.


Kate Davis, MD, MSTR: Referring Patients to An Epileptologist

Kate Davis, MD, MSTR: Referring Patients to An Epileptologist

November 1st 2018

The epileptologist discussed this challenge, and shared her thoughts on how to maintain this communication.


Claire Henchcliffe, MD, DPhil: Dopaminergic Cell Replenishment in Parkinson Disease

Claire Henchcliffe, MD, DPhil: Dopaminergic Cell Replenishment in Parkinson Disease

October 31st 2018

The associate professor of neurology and neuroscience at Weill Cornell Medicine discussed this work, and what she and her colleagues believe could be addressed by a successful effort.


Bernd Feige, PhD: Insomnia and the REM Sleep State

Bernd Feige, PhD: Insomnia and the REM Sleep State

October 30th 2018

The study presents direct evidence that subjective experiences of insomnia may be coupled to the REM sleep state.


Spinal Muscular Atrophy, Questions That Remain Unanswered

Spinal Muscular Atrophy, Questions That Remain Unanswered

October 30th 2018

Darryl De Vivo, MD, emphasized that while there's been a tremendous advance in the field of SMA, it’s important to continue tinkering around the margins to make the effective treatment increasingly better.


George Koshy Vilanilam, MBBS: Migraine as a Risk Factor for Ischemic Stroke

George Koshy Vilanilam, MBBS: Migraine as a Risk Factor for Ischemic Stroke

October 29th 2018

The study found that there has been a significant increasing trend in patients with migraine—irrespective of aura status—having an ischemic stroke.


Spinal Muscular Atrophy, From Bench to Bedside

Spinal Muscular Atrophy, From Bench to Bedside

October 29th 2018

The Sidney Carter Professor of Neurology at Columbia University Medical Center spoke about the 127 year history of spinal muscular atrophy and how basic science has led to exciting developments.


Anna Heidbreder, MD: Anti-IgLON5 Disease, REM Sleep Behavior Disorder

Anna Heidbreder, MD: Anti-IgLON5 Disease, REM Sleep Behavior Disorder

October 28th 2018

Heidbreder further described the current understanding of the condition and what she and her colleagues have found out.


Peter Calabresi, MD: Utilizing A Uniform Biomarker Assay

Peter Calabresi, MD: Utilizing A Uniform Biomarker Assay

October 27th 2018

For the director of the Johns Hopkins Multiple Sclerosis Center, a biomarker is perhaps only as useful as the clinician community’s ability to read out its measurements.


Thorsten Mikoteit, MD: Sleep Research, an Excellent Source for Biomarkers

Thorsten Mikoteit, MD: Sleep Research, an Excellent Source for Biomarkers

October 26th 2018

The Psychiatrist at Psychiatric Services Solothurn and University of Basel discussed how heart rate variability correlates with sleep stages, which may indicate nocturnal brain activity.


Jeff Waugh, MD, PhD: Viewing Striatal Injury More Granularly

Jeff Waugh, MD, PhD: Viewing Striatal Injury More Granularly

October 25th 2018

Despite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.


Thorsten Mikoteit, MD: Sleep Biomarkers in Insomnia

Thorsten Mikoteit, MD: Sleep Biomarkers in Insomnia

October 24th 2018

Under treatment, the dynamic of REM sleep related heart rate variability shows early changes during the first week, providing a promising biomarker of treatment.


David Holtzman, MD: Difficulties Identifying Dementia With Lewy Bodies

David Holtzman, MD: Difficulties Identifying Dementia With Lewy Bodies

October 23rd 2018

The current president of the American Neurological Association specifically mentioned the work some groups are doing with small molecule imaging methods to help with this issue.


ITI-214 Safe With Signs of Efficacy in Phase 1/2 Parkinson Disease Study

ITI-214 Safe With Signs of Efficacy in Phase 1/2 Parkinson Disease Study

October 23rd 2018

ITI-214 showed favorable safety with early signs of improvement in motor symptoms for patients with Parkinson disease


Elizabeth Ross, MD, PhD: Improving the Field By Understanding Mechanisms

Elizabeth Ross, MD, PhD: Improving the Field By Understanding Mechanisms

October 23rd 2018

The director of the Center of Neurogenetics at Weill Cornell Medicine spoke about the wealth of improvements that have really turned this area of medicine into a much more hopeful one.


Anti-CGRP Monoclonal Antibodies Transforming Migraine Treatment

Anti-CGRP Monoclonal Antibodies Transforming Migraine Treatment

October 23rd 2018

The CGRP inhibitors are poised to transform the treatment paradigm for patients with migraine and cluster headache.

© 2025 MJH Life Sciences

All rights reserved.